Citations
Alveolar hemorrhage associated with tirofiban
Hemorragia alveolar asociada con tirofiban
Open | Download
Section
Case Reports
How to Cite
Aguilar Arias, A., Martínez, C. A. ., Arango, A. M. ., Vélez Garcés, S. ., & Aguilar Arias, C. (2023). Alveolar hemorrhage associated with tirofiban. Journal of Medicine and Surgery Repertoire, 34(1), 95-97. https://doi.org/10.31260/RepertMedCir.01217372.1427
Dimensions
license
Show authors biography
Case: we present a patient with alveolar hemorrhage associated with tirofiban, whose diagnosis was delayed because the initial signs, which were misinterpreted as pneumonia, were unrecognized. Discussion and conclusions: an early and accurate diagnosis is essential to guide the appropriate management of any type of bleeding complication in a patient with acute coronary syndrome (ACS), especially in a case of alveolar hemorrhage (AH).
Article visits 210 | PDF visits 152
Downloads
Download data is not yet available.
- Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87-165. https://doi.org/10.1093/eurheartj/ehy394. DOI: https://doi.org/10.1093/eurheartj/ehy855
- Collet JP, Thiele H, Barbato E, Barthélémy O, Bauersachs J, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289-1367. https://doi.org/10.1093/eurheartj/ehaa575. DOI: https://doi.org/10.1093/eurheartj/ehaa575
- Hu X, Wang W, Ye J, Lin Y, Yu B, Zhou L, Zhou Y, Dong H. Effect of GP IIb/IIIa inhibitor duration on the clinical prognosis of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction with no-/slow-reflow phenomenon. Biomed Pharmacother. 2021;143:112196. https://doi.org/10.1016/j.biopha.2021.112196. DOI: https://doi.org/10.1016/j.biopha.2021.112196
- Bor WL, Zheng KL, Tavenier AH, Gibson CM, Granger CB, et al. Pharmacokinetics, pharmacodynamics, and tolerability of subcutaneous administration of a novel glycoprotein IIb/IIIa inhibitor, RUC-4, in patients with ST-segment elevation myocardial infarction. EuroIntervention. 2021;17(5):e401-e410. https://doi.org/10.4244/EIJ-D-21-00287. DOI: https://doi.org/10.4244/EIJ-D-21-00287
- Karathanos A, Lin Y, Dannenberg L, et al. Routine Glycoprotein IIb/IIIa Inhibitor Therapy in ST-Segment Elevation Myocardial Infarction: A Meta-analysis. Can J Cardiol. 2019;35(11):1576-1588. https://doi.org/10.1016/j.cjca.2019.05.003. DOI: https://doi.org/10.1016/j.cjca.2019.05.003
- Zhou X, Peng H, Yin Y, Huang H, Zeng J, Ouyang F. Diffused alveolar hemorrhage: A rare and severe complication of tirofiban-induced thrombocytopenia. International Journal of Cardiology. 2016;206:93-94. https://doi.org/10.1016/j.ijcard.2016.01.020. DOI: https://doi.org/10.1016/j.ijcard.2016.01.020
Submissions
Tutorials
About journal
Information
Keywords
Indexed in
Google Scholar profile
QR code
Most read in the last 30 days
